OpenAI acquires AI biotech startup Orchestra Bio to expand Rosalind life sciences platform
OpenAI announced on 2026-10-20 that it acquired Orchestra Bio, a four-year-old AI biotech software startup. Deal terms were not disclosed. Orchestra had reportedly raised about $20 million as of 2025 from backers including Andreessen Horowitz, Atria and 8VC. Orchestra builds AI agents that help biotech companies manage drug discovery oper…